4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-24-048026
Options or other derivatives
- Chief Executive Officer acquired 315,421 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Huntsman Ronald Kirk Chief Executive Officer | 2024-11-26 | Grant or award · Stock Option (Right to Buy) | +315,421 | $2.64 | $832,711 | 364,755 | D |
Loading xslF345X05/ownership.xml…